Denali Capital Acquisition Corp. (NASDAQ: DECA) and Longevity Biomedical, Inc. have mutually agreed to terminate their previously announced business combination agreement. Denali, a Cayman Islands exempted blank check company, is now seeking alternative ways to complete an initial business combination. The decision to terminate the agreement underscores the uncertainties and risks inherent in forward-looking business combinations. Denali’s intention remains to find a suitable target for a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination.

Private Equity, Healthcare, Investment Banking & Financial Services,United States, Cayman Islands